HIL Applied Medical - page 3
Dr. Moshe Fraenkel of Soreq NRC joins HIL’s R&D team Dr. Fraenkel is an experimental plasma physicist in the field of high-intensity laser matter interaction. He has over 20 years’ experience in hands-on research as well as supervision of research …
Continue reading »Arik Hybloom, CPA , joins HIL as Director of Finance A CPA (Israel) for the past 18 years, formerly with Deloitte, Arik brings substantive experience in management, banking and finance. Prior to joining HIL, Arik served as COO and CFO at …
Continue reading »HIL granted two new patents – including a first in China Last week the USPTO granted HIL yet another patent in the field of laser-based particle acceleration. Today it was joined by the Chinese CTPO, granting HIL its first patent in China. …
Continue reading »Brian Krolicki joins HIL’s Advisory Board A veteran of the private banking industry and multiple-time Nevada Lieutenant Governor and State Treasurer, Brian began his career on Wall Street working with high-profile firms such as Smith Barney and Bankers Trust Company. A …
Continue reading »IBA invests in HIL Applied Medical Ltd to develop laser-based proton therapy system Potential of new technology to further reduce cost and size of proton therapy systems Louvain-la-Neuve, Belgium and Jerusalem, Israel, August 23, 2016 – IBA (Ion Beam Applications …
Continue reading »Dr. Jesse Adams joins HIL as VP, North America Dr. Adams joined HIL following the acquisition of NanoLabz, where he was Co-Founder and Vice President; there he led the development and fabrication of smart nano-engineered targets for the short-pulse laser …
Continue reading »Prof. Yehoshua (Shuki) Shemer joins HIL’s Board of Directors Professor Shemer is Chairman of the Board of Assuta Israel, the country’s largest private hospital network. He is also Director of the Israeli Center for Technology Assessment in Health Care (ICTAHC) …
Continue reading »Jerusalem Day interview: Jon Medved hosts Sagi Brink-Danan, CEO of HIL Applied Medical In honor of Jerusalem Day (June 5th, 2016), OurCrowd CEO Jonathan Medved interviews Sagi Brink-Danan, CEO of HIL Applied Medical, about the city’s startup ecosystem, growing high-tech …
Continue reading »Israeli startup HIL Applied Medical Ltd. acquires US-Based Nanolabz Inc. – en route to developing advanced cancer radiotherapy systems Jerusalem, Israel and Reno, Nevada. May 26, 2016 – HIL Applied Medical Ltd. – a Jerusalem, Israel medical technology startup – has …
Continue reading »HIL’s CEO to present at the annual OurCrowd Global Investor Summit The 2nd Annual OurCrowd Global Investor Summit will take place at the ICC – Israeli Convention Center (Binyanei Ha’Umah) – in Jerusalem, January 25-26th, 2016. Among many other exciting things it …
Continue reading »